HYPERRAB
Google image searchProduct monograph
Active ingredient
rabies immunoglobulin (human), 300 UNIT/ML
DIN: 02486571
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR
Schedule: Schedule D
Company: GRIFOLS THERAPEUTICS LLC
Date: 02-JUL-2019
ATC:
- J06 — IMMUNE SERA AND IMMUNOGLOBULINS (ATC, ATC/DDD, )
- J06B — IMMUNOGLOBULINS (ATC, ATC/DDD)
- J06BB — Specific immunoglobulins (ATC, ATC/DDD)
- J06BB05 — RABIES IMMUNOGLOBULIN (ATC/DDD)
Reference brand drug: Hyperrab, Kamrab
Pharmaceutical standard: MFR
